Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 2
1955 1
1956 2
1957 4
1960 3
1961 2
1962 4
1963 4
1964 6
1965 9
1966 9
1967 8
1968 16
1969 6
1970 9
1971 9
1972 4
1973 6
1974 10
1975 11
1976 11
1977 3
1978 10
1979 13
1980 10
1981 12
1982 11
1983 5
1984 17
1985 20
1986 14
1987 22
1988 12
1989 24
1990 29
1991 29
1992 30
1993 32
1994 29
1995 36
1996 38
1997 48
1998 40
1999 41
2000 48
2001 48
2002 57
2003 50
2004 49
2005 60
2006 66
2007 56
2008 62
2009 65
2010 65
2011 76
2012 103
2013 96
2014 109
2015 131
2016 129
2017 122
2018 129
2019 136
2020 166
2021 132
2022 86
2023 109
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

2,578 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team. Howard JF Jr, et al. Among authors: masuda m. Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T. Akiyama T, et al. Among authors: masuda m. Cancer Res. 2023 Mar 2;83(5):753-770. doi: 10.1158/0008-5472.CAN-22-1890. Cancer Res. 2023. PMID: 36543251
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, Tanaka H, Azekawa S, Mikami Y, Lee H, Hasegawa T, Okudela K, Okuzaki D, Motooka D, Kanai M, Naito T, Yamamoto K, Wang QS, Saiki R, Ishihara R, Matsubara Y, Hamamoto J, Hayashi H, Yoshimura Y, Tachikawa N, Yanagita E, Hyugaji T, Shimizu E, Katayama K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Aoki R, Nakamura A, Harada S, Sasano H, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, Nanki K, Uchida S, Uno S, Nishimura T, Ishiguro T, Isono T, Shibata S, Matsui Y, Hosoda C, Takano K, Nishida T, Kobayashi Y, Takaku Y, Takayanagi N, Ueda S, Tada A, Miyawaki M, Yamamoto M, Yoshida E, Hayashi R, Nagasaka T, Arai S, Kaneko Y, Sasaki K, Tagaya E, Kawana M, Arimura K, Takahashi K, Anzai T, Ito S, Endo A, Uchimura Y, Miyazaki Y, Honda T, Tateishi T, Tohda S, Ichimura N, Sonobe K, Sassa CT, Nakajima J, Nakano Y, Nakajima Y, Anan R, Arai R, Kurihara Y, Harada Y, Nishio K, Ueda T, Azuma M, Saito R, Sado T, Miyazaki Y, Sato R, Haruta Y, Nagasaki T, Yasui Y, Hasegawa Y, Mutoh Y, Kimura T, Sato T, Takei R, Hagimoto S,… See abstract for full author list ➔ Namkoong H, et al. Among authors: masuda m. Nature. 2022 Sep;609(7928):754-760. doi: 10.1038/s41586-022-05163-5. Epub 2022 Aug 8. Nature. 2022. PMID: 35940203 Free PMC article.
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K. Uzawa A, et al. Among authors: masuda m. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):467-473. doi: 10.1136/jnnp-2022-330519. Epub 2023 Jan 24. J Neurol Neurosurg Psychiatry. 2023. PMID: 36693723
Wellens' Syndrome.
Masuda M, Sakamoto T, Shimizu T. Masuda M, et al. Am J Med Sci. 2021 Oct;362(4):e37-e38. doi: 10.1016/j.amjms.2021.02.015. Epub 2021 Feb 20. Am J Med Sci. 2021. PMID: 33621528 No abstract available.
Primary Gastric Rhabdomyosarcoma.
Nakamura N, Suzuki R, Takahashi Y, Uwamori A, Masuda M, Fukui T, Noda Y, Tsuta K, Naganuma M. Nakamura N, et al. Among authors: masuda m. Intern Med. 2023 Dec 1;62(23):3483-3488. doi: 10.2169/internalmedicine.1645-23. Epub 2023 Apr 21. Intern Med. 2023. PMID: 37081684 Free PMC article.
Protothecosis in Dogs and Cats-New Research Directions.
Masuda M, Jagielski T, Danesi P, Falcaro C, Bertola M, Krockenberger M, Malik R, Kano R. Masuda M, et al. Mycopathologia. 2021 Mar;186(1):143-152. doi: 10.1007/s11046-020-00508-y. Epub 2020 Nov 18. Mycopathologia. 2021. PMID: 33206310 Review.
Malignant pleural mesothelioma in situ.
Ando K, Morohoshi T, Tsuura Y, Masuda M. Ando K, et al. Among authors: masuda m. Interact Cardiovasc Thorac Surg. 2022 Oct 10;35(5):ivac255. doi: 10.1093/icvts/ivac255. Interact Cardiovasc Thorac Surg. 2022. PMID: 36205712 Free PMC article.
2,578 results